SeqLL Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 2

SeqLL General Information

Description

Developer of molecule sequencing technology designed for research and healthcare communities. The company's technology offers quantitative RNA and specialty DNA sequencing services to provide raw data as well as full-service bioinformatics support and summary reports, enabling physicians to optimizes the breadth of data collected with turn-around time and cost.

Contact Information

Website
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Biotechnology
Primary Office
  • 317 New Boston Street
  • Suite 210
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000

SeqLL Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SeqLL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 27-Apr-2020 000 Completed
4. IPO 23-Apr-2019 00.000 000.00 Cancelled Generating Revenue/Not Profitable
3. Grant 01-Jan-2017 00000 000 Completed Generating Revenue
2. Angel (individual) 19-Feb-2016 $1M $2M 000.00 Completed Generating Revenue
1. Angel (individual) 18-Sep-2014 $1M $1M 00.00 Completed Startup
To view SeqLL’s complete valuation and funding history, request access »

SeqLL Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view SeqLL’s complete cap table history, request access »

SeqLL Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of molecule sequencing technology designed for research and healthcare communities. The company's technology o
Biotechnology
Woburn, MA
12 As of 2019
000
000000000 - 000

0000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000000000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000

000 000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000000000000
South Plainfield, NJ
0 As of 0000
00.000
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SeqLL Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Omniome Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
000 000 Formerly VC-backed South Plainfield, NJ 0 00.000 000000&0 00.000
0000 000000 Corporation Madrid, Spain 00.00 000000000000 00.00
0000000 Corporation Seoul, South Korea 00
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
You’re viewing 5 of 29 competitors. Get the full list »

SeqLL Executive Team (3)

Name Title Board Seat Contact Info
Daniel Jones Co-Founder, Board Member, President & Chief Executive Officer
William Laurent Co-Founder & Chairman
To view SeqLL’s complete executive team members history, request access »

SeqLL Board Members (3)

Name Representing Role Since
David Pfeffer SeqLL Board Member 000 0000
Douglas Miscoll Self Board Member 000 0000
William Laurent SeqLL Co-Founder & Chairman 000 0000
To view SeqLL’s complete board members history, request access »

SeqLL Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SeqLL Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Genomic Diagnostic Technologies Other Minority 000 0000 000000 0
To view SeqLL’s complete investors history, request access »